Hitomi Sudo - Concepedia

Author

Hitomi Sudo

National Institutes for Quantum Science and Technology ORCID

Also Known As

H SUDO, H Sudo, H. SUDO, HITOMI SUDO, Hitomi Sudo

Publications

Citations

H-Index

Concepts

All Affiliations

National Institutes for Quantum Science and Technology Juntendo University Fujita Health University Chiba University The Cancer Institute Hospital

About

Hitomi Sudo is an author at National Institutes for Quantum Science and Technology specializing in medicine, radiation oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	328
2	Engineering	4	4	89
3	Allergy	3	3	85
4	Health Sciences	1	1	24
5	Natural Sciences	1	1	13

Hitomi Sudo

Publications

895

Citations

H-Index

Page 1

	Year	Citations
Antitumor effects of radionuclide treatment using α-emitting meta-211At-astato-benzylguanidine in a PC12 pheochromocytoma model Yasuhiro Ohshima, Hitomi Sudo, Shigeki Watanabe, European Journal of Nuclear Medicine and Molecular Imaging	2018	90
Knockdown of COPA, Identified by Loss-of-Function Screen, Induces Apoptosis and Suppresses Tumor Growth in Mesothelioma Mouse Model Hitomi Sudo, Atsushi B. Tsuji, Aya Sugyo, Genomics Suppresses Tumor GrowthLoss-of-function ScreenMedicineApoptosisCell Death	2010	63
AHNAK is highly expressed and plays a key role in cell migration and invasion in mesothelioma Hitomi Sudo, Atsushi B. Tsuji, Aya Sugyo, International Journal of Oncology Tumor BiologyTumoral PathologyKey RoleGliomaMalignant Disease	2013	48
Eosinophilic pustular folliculitis effectively treated with recombinant interferon-gamma: suppression of mRNA expression of interleukin 5 in peripheral blood mononuclear cells. Masahito Fushimi, Y. Tokura, Y. SACHI, PubMed Mrna ExpressionImmunologyEosinophilic DisorderDermatologyImmunotherapy	1996	45
Evaluation of 89Zr-Labeled Human Anti-CD147 Monoclonal Antibody as a Positron Emission Tomography Probe in a Mouse Model of Pancreatic Cancer Aya Sugyo, Atsushi B. Tsuji, Hitomi Sudo, PLoS ONE	2013	38
Preclinical Evaluation of the Acute Radiotoxicity of the α-Emitting Molecular-Targeted Therapeutic Agent 211At-MABG for the Treatment of Malignant Pheochromocytoma in Normal Mice Hitomi Sudo, Atsushi B. Tsuji, Aya Sugyo, Translational Oncology	2019	37
ZDHHC8 knockdown enhances radiosensitivity and suppresses tumor growth in a mesothelioma mouse model Hitomi Sudo, Atsushi B. Tsuji, Aya Sugyo, Cancer Science Tumor BiologyOncologyGliomaRadiation TherapyMedicine	2011	34
Evaluation of Efficacy of Radioimmunotherapy with 90Y-Labeled Fully Human Anti-Transferrin Receptor Monoclonal Antibody in Pancreatic Cancer Mouse Models Aya Sugyo, Atsushi B. Tsuji, Hitomi Sudo, PLoS ONE	2015	33
Therapeutic Efficacy of C-Kit-Targeted Radioimmunotherapy Using 90Y-Labeled Anti-C-Kit Antibodies in a Mouse Model of Small Cell Lung Cancer Chisato Yoshida, Atsushi B. Tsuji, Hitomi Sudo, PLoS ONE	2013	31
FZD10‐targeted α‐radioimmunotherapy with <sup>225</sup>Ac‐labeled OTSA101 achieves complete remission in a synovial sarcoma model Hitomi Sudo, Atsushi B. Tsuji, Aya Sugyo, Cancer Science	2021	30

Page 1